169 related articles for article (PubMed ID: 28756771)
21. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
[TBL] [Abstract][Full Text] [Related]
22. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma.
Qin C; Yang S; Sun X; Xia X; Li C; Lan X
Clin Nucl Med; 2019 Mar; 44(3):201-208. PubMed ID: 30624268
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
25. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
26. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
[TBL] [Abstract][Full Text] [Related]
27. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
[TBL] [Abstract][Full Text] [Related]
28. A novel prognostic model for extranodal natural killer/T-cell lymphoma.
Huang JJ; Zhu YJ; Xia Y; Zhao W; Lin TY; Jiang WQ; Huang HQ; Li ZM
Med Oncol; 2012 Sep; 29(3):2183-90. PubMed ID: 21786011
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group.
Shen Z; Zhang S; Chen X; Zhang Q; Jiao Y; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Wang L; Cai G; Sang W
Hematol Oncol; 2023 Aug; 41(3):380-388. PubMed ID: 36680513
[TBL] [Abstract][Full Text] [Related]
30. Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer/T-cell lymphoma.
Luo H; Quan X; Song XY; Zhang L; Yin Y; He Q; Cai S; Li S; Zeng J; Zhang Q; Gao Y; Yu S
Oncotarget; 2017 Nov; 8(54):92522-92535. PubMed ID: 29190934
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Bai B; Huang HQ; Cai QC; Fan W; Wang XX; Zhang X; Lin ZX; Gao Y; Xia YF; Guo Y; Cai QQ; Jiang WQ; Lin TY
Med Oncol; 2013 Mar; 30(1):339. PubMed ID: 23329306
[TBL] [Abstract][Full Text] [Related]
32. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
33. Dynamic evaluation of the prognostic value of
Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
[TBL] [Abstract][Full Text] [Related]
34. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
[TBL] [Abstract][Full Text] [Related]
35. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
Chen Z; Fang X; Huang H; Wang Z; Hong H; Chen M; Ren Q; Yao Y; Zhang L; Tian Y; Lin S; Lin T
Ann Hematol; 2020 Dec; 99(12):2811-2819. PubMed ID: 32975588
[TBL] [Abstract][Full Text] [Related]
36. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Jiang M; Wu WC; Zou LQ
Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
[TBL] [Abstract][Full Text] [Related]
37. Expression of TIM-3 and LAG-3 in extranodal NK/T cell lymphoma, nasal type.
Feng Y; Zhong M; Liu Y; Wang L; Tang Y
Histol Histopathol; 2018 Mar; 33(3):307-315. PubMed ID: 28901003
[TBL] [Abstract][Full Text] [Related]
38. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
40. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
